Fapon · 1 day ago
Key Account Manager
Maximize your interview chances
Insider Connection @Fapon
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
For customizing the plan according to strategies of the Global key accounts (Top IVD companies), and coordinating the team to complete the sales target.
To the company's overseas market strategic layout, conduct breakthroughs in new R&D projects for the top IVD customers, improving Fapon’s visibility and reputation in the high-end IVD market.
And feedback information on competitors and market dynamics
Good relationships with industry KOLs and Academic related organizations.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
degree and above, Biotechnology, bioengineering and other related majors.
least 5 years of sales/ product /R&D experience in IVD raw materials/reagents or instruments.
Familiar with special need the people from the top 15 IVD companies in the world or the raw materials companies in Europe or U.S.
willing to adapt to and grow in a multi-national Chinese company.
Preferred
an excellent cooperative relationship with IVD companies in the world, familiar with the enterprise R&D decision-making process or familiar with the decision-making key person
Benefits
Financial security through competitive compensation, incentives, and retirement plan
Health care and well-being programs including competitive medical, dental, vision & medical benefits
Generous paid time off including vacation, sick time, holidays, and discretionary winter shutdown
401(k) retirement savings with a generous company match
Commuter benefits
Other comprehensive voluntary benefits include but are not limited to pet insurance, life insurance, employee assistance program (EAP), discount programs, and many more
Company
Fapon
Fapon is a global leading life sciences company dedicated to providing integrated solutions and services for diagnostics, biopharma and biotherapy.
Funding
Current Stage
Public CompanyTotal Funding
$1.74M2019-01-01Post Ipo Equity
2017-05-16Post Ipo Equity· $1.74M
2016-08-18IPO
Company data provided by crunchbase